Article


A Case Report of Kikuchi-Fujimoto Disease in a Young Iranian Woman and Review of the Literature

Masoumi, M.1,2*, Amirkanian, F.1, Baghban, M.1, Tabaraei, R.1, Salevati Pour, A.1 & Mullabashi, T.1

1Qom University of Medical Sciences (QUMS), Shahid Beheshti Hospital, Qom, Iran
2Rheumatology Research Center (RRC), Tehran University of Medical Science, Shariati Hospital, Tehran, Iran

Masoumi, M., Qom University of Medical Sciences (QUMS) and Rheumatology Research Center (RRC), Iran.

Keywords: Immunophenotype; Etiopathogenesis; Hematoxylin; Corticosteroid therapy

Abstract

Kikuchi-Fujimoto disease (KFD) or histiocytic necrotizing lymphadenitis is a rare, benign, generally self-limiting disease first described in 1972. KFD generally affects Asian women between the ages of 20 and 35 years old. It frequently manifests as an acute or subacute form with painful posterior cervical lymphadenopathy and systemic symptoms like fever, fatigue, and headache [1-4]. More rarely, patients with KFD can also present with leukopenia, hepatosplenomegaly and complaints of fatigue, rash, arthralgia and weight loss [5].

View Full Text | Download PDF

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Total Articles Published

8
9
2


Total Citations:

1
8
4




Highlights


Cient Periodique is a ‘Gold’ open access publisher that aspires to offer absolute free, unrestricted access to the valuable research information

We welcome all the eminent authors to submit your valuable paper

Cient Periodique invites the participation of honourable Editors and Authors

CPQ Journals provide Certificates for publication

Cient Periodique also offers memberships for potential Authors

Best Articles will be appreciated with the provision of corresponding Certificate

Hi!

We're here to answer your questions!


Send us a message via Whatsapp, and we'll reply the moment we're available!